A compact VEGF signature associated with distant metastases and poor outcomes
暂无分享,去创建一个
C. Fan | C. Perou | M. Rijn | M. van de Rijn | O. Olopade | Xiaping He | L. Carey | C. Livasy | Subbaya Subramanian | D. Oh | M. Ewend | F. Ikpatt | Robert B. West | Zhi-An Hu | Zhiyuan Hu | L. Carey | Cheng Fan | Chad Livasy | Daniel S Oh | Robert West | Francis Ikpatt
[1] G. Moreno-Bueno,et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.
[2] K. Caron,et al. Adrenomedullin signaling is necessary for murine lymphatic vascular development. , 2008, The Journal of clinical investigation.
[3] Crispin J. Miller,et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. , 2007, Cancer research.
[4] G. Sledge,et al. Drug Insight: VEGF as a therapeutic target for breast cancer , 2007, Nature Clinical Practice Oncology.
[5] Charles M Perou,et al. Gene expression patterns associated with p53 status in breast cancer , 2006, BMC Cancer.
[6] A. Nobel,et al. Concordance among gene-expression-based predictors for breast cancer. , 2006, The New England journal of medicine.
[7] Yudi Pawitan,et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients , 2006, Breast Cancer Research.
[8] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[9] Zhiyuan Hu,et al. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Y. Sadovsky,et al. N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury* , 2006, Journal of Biological Chemistry.
[11] C. Perou,et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.
[12] Gavin D. Grant,et al. Common markers of proliferation , 2006, Nature Reviews Cancer.
[13] Trevor Hastie,et al. Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers , 2006, PLoS medicine.
[14] C. Perou,et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.
[15] Robert D Cardiff,et al. The transcriptional repressor Snail promotes mammary tumor recurrence. , 2005, Cancer cell.
[16] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[17] Mina J Bissell,et al. Myoepithelial cells: good fences make good neighbors , 2005, Breast Cancer Research.
[18] T. Miyata,et al. [Functional analyses of NDRG1, a stress-responsive gene]. , 2005, Seikagaku. The Journal of Japanese Biochemical Society.
[19] B. Han,et al. Urokinase-type plasminogen activator system and breast cancer (Review). , 2005, Oncology reports.
[20] S. Frede,et al. The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. , 2005, Cancer research.
[21] G. Glinsky,et al. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. , 2005, The Journal of clinical investigation.
[22] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[24] Wolfgang Arnold,et al. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase , 2005, Oncogene.
[25] A. Harris,et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer , 2005, Journal of Clinical Pathology.
[26] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[27] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[28] D. Rimm,et al. X-Tile , 2004, Clinical Cancer Research.
[29] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[30] C. Ball,et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. , 2004, The American journal of pathology.
[31] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[32] C. Perou,et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. , 2004, Cancer cell.
[33] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[34] Annuska M Glas,et al. Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] Brad T. Sherman,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[36] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[38] T. Golub,et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.
[39] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[40] Charles M. Perou,et al. A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines , 2002, Disease markers.
[41] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[42] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] Zena Werb,et al. Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.
[44] L. Pachter,et al. rVista for comparative sequence-based discovery of functional transcription factor binding sites. , 2002, Genome research.
[45] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[46] R. Leek,et al. The prognostic role of angiogenesis in breast cancer. , 2001, Anticancer research.
[47] Carsten O. Peterson,et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.
[48] M. Moses,et al. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. , 2001, Cancer research.
[49] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[50] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[51] R. Weigel,et al. GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.
[52] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] Bongsoo Park,et al. BMC Genomics , 2007 .
[54] C. Perou,et al. High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays. , 2005, BioTechniques.
[55] Joel S. Parker,et al. Adjustment of systematic microarray data biases , 2004, Bioinform..
[56] BMC Genomics BioMed Central Methodology article Universal Reference RNA as a standard for microarray experiments , 2004 .
[57] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[58] René Bernards,et al. A progression puzzle. , 2002, Nature.
[59] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[60] G. Semenza,et al. 'The metabolism of tumours': 70 years later. , 2001, Novartis Foundation symposium.
[61] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[62] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.